98% Paxalisib (GDC-0084) Powder In Stock For Sale
Looking For Leading Paxalisib Manufacturers In China? Contact Us Now!
Why You Choose Us As Your Paxalisib Supplier?
#1. Small molecules in stock ready for fast shipping:
We stock freshly manufactured pure powder for prompt shipment.
#2. Low MOQ with an affordable bulk price.
To make sure all researchers have affordable pure powder for research, our MOQ starts from 1G.
We can also do repacking right after your PO.
#3. Testing spectra are available for order confirmation.
1HNMR and LC-MS spectra for each batch are available for your structure and specific purity confirmation before order.
What Is Paxalisib?
Cas number: 1382979-44-3
Molecular formula: C18H22N8O2
Molecular weight: 328.4 g/mol
Chemical Name: 5-(6,6-dimethyl-4-morpholin-4-yl-8,9-dihydropurino[8,9-c][1,4]oxazin-2-yl)pyrimidin-2-amine
HS Code: 2934999099 (Other heterocyclic compounds-其它杂环化合物)
Paxalisib, also known as GDC-0084, is a white to off-white powder.
It is a small molecule potentially developed for the treatment of glioblastoma.
Glioblastoma is one of the most commonly seen and malignant brain cancers.
Its clinical trial of the treatment has gone into phase II in 2016.
It is originally marketed and developed by Genentech and it has great potential to save thousands of lives shortly.
What Is Paxalisib Used For?
Paxalisib is mainly used to treat glioblastoma, a type of brain cancer.
It is a type of targeted therapy that works by inhibiting the activity of a protein called PI3K, which is involved in the growth and spread of cancer cells.
It is typically used in people with glioblastoma who have already been treated with chemotherapy and other medications, but whose cancer has continued to grow or spread.
It is usually given as an intravenous (IV) infusion, which means that it is delivered directly into a vein through a small tube.
The main use of paxalisib is to slow the growth and spread of glioblastoma.
In clinical trials, it has been shown to improve progression-free survival, which is the length of time that a person lives without their cancer growing or spreading. However, it is not a cure for glioblastoma, and it does not work for everyone.
In addition to its use in treating glioblastoma, paxalisib is also being studied as a potential treatment for other types of cancer, including prostate cancer, pancreatic cancer, and lung cancer.
More research is needed to determine the effectiveness and safety of these conditions.
